Uday Kompella
Founder presso OCUGEN, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Uday B.
Kompella is a Director & Chief Scientific Officer, Independent Director, and Director at Ocugen, Inc. and Ocugen OpCo, Inc. respectively, both founded in 2013.
He is also a Professor-Pharmaceutical Sciences at CU Anschutz Medical Campus.
Dr. Kompella holds a doctorate from the University of Southern California, an undergraduate degree from Birla Institute of Technology & Science, and a graduate degree from Jadavpur University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OCUGEN INC
0.27% | 09/06/2023 | 705 090 ( 0.27% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Uday Kompella
| Società | Posizione | Inizio |
|---|---|---|
| OCUGEN, INC. | Founder | 01/01/2013 |
| Ocugen OpCo, Inc. | Founder | 01/09/2013 |
| CU Anschutz Medical Campus | Corporate Officer/Principal | - |
Precedenti posizioni note di Uday Kompella
| Società | Posizione | Fine |
|---|---|---|
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Founder | - |
Formazione di Uday Kompella
| University of Southern California | Doctorate Degree |
| Birla Institute of Technology & Science | Undergraduate Degree |
| Jadavpur University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
- Borsa valori
- Insiders
- Uday Kompella
